AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionLaraway Financial Inc
Latest Disclosed Ownership1,468 shares
Latest Disclosed Value $ 319,188
Laraway Financial Inc reports 16.92% decrease in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Laraway Financial Inc filed a 13F-HR form disclosing ownership of 1,468 shares of AbbVie Inc. (BG:4AB) valued at $319,188 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,767 shares of AbbVie Inc.. This represents a change in shares of -16.92% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 1,468 -299 -16.92 319 -20.84 0.2244
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 1,767 -5 -0.28 404 -1.71 0.2631
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 1,772 0 0.00 410 25.00 0.2801
2025-07-23 2025-06-30 13F ABBVIE COM 00287Y109 1,772 -24 -1.34 329 -12.77 0.2495
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 1,796 1 0.06 376 17.87 0.2990
2025-02-14 2024-12-31 13F ABBVIE COM 00287Y109 1,795 0 0.00 319 -9.89 0.2458
2024-11-15 2024-09-30 13F ABBVIE COM 00287Y109 1,795 0 0.00 355 15.31 0.2827
2024-08-13 2024-06-30 13F ABBVIE COM 00287Y109 1,795 1 0.06 308 -5.83 0.2630
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 1,794 0 0.00 327 17.69 0.2881
2024-02-07 2023-12-31 13F ABBVIE COM 00287Y109 1,794 1 0.06 278 3.75 0.2641
2023-11-16 2023-09-30 13F ABBVIE COM 00287Y109 1,793 -25 -1.38 267 9.43 0.2785
2023-07-28 2023-06-30 13F ABBVIE COM 00287Y109 1,818 1 0.06 245 -15.57 0.2422
2023-06-09 2023-03-31 13F ABBVIE COM 00287Y109 1,817 0 0.00 290 -1.37 0.2935
2023-02-22 2022-12-31 13F ABBVIE COM 00287Y109 1,817 -33 -1.78 294 18.15 0.3070
2022-11-15 2022-09-30 13F ABBVIE COM 00287Y109 1,850 0 0.00 248 -12.37 0.2770
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 1,850 -50 -2.63 283 -7.82 0.3012
2022-05-17 2022-03-31 13F ABBVIE COM 00287Y109 1,900 50 2.70 307 22.80 0.2797
2022-02-11 2021-12-31 13F ABBVIE COM 00287Y109 1,850 1,850 250 0.2232
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.